推荐应用
B- and T-lymphocyte attenuator (BTLA; CD272) is a 35 kDa type I transmembrane glycoprotein in the CD28 family of T cell costimulatory molecules. The ECD of human BTLA shares 42% and 44% aa identity with that of mouse and rat BTLA, respectively. BTLA is also unusual in its interaction with the TNF superfamily member HVEM rather than with B7 family ligands. BTLA is expressed on T cells, B cells, macrophages, dendritic cells, and NK cells. Its expression is low in naïve T cells and increases during antigen-specific induction of anergy. In B cells, BTLA expression is highest in mature naïve cells. BTLA apparently limits T cell numbers, since its deletion results in overproduction of T cells, especially CD8+ memory T cells that are hyper-responsive to TCR crosslinking.
高纯度、高活性、低内毒素、高批间一致性
产品数据
Tris-Bis PAGE


-25 ~ -15℃保存,收到货之后有效期1年。 复溶后, 无菌条件下,-85 ~ -65℃保存,3个月有效期。
【应用方向】BCMA/TNFRSF17:多发性骨髓瘤免疫治疗的核心靶点蛋白
140
2026-08-31
【应用方向】CD20:B细胞恶性肿瘤免疫治疗的核心靶点蛋白
148
2026-08-31
【应用方向】CD19:血液肿瘤免疫治疗的核心靶点蛋白
164
2026-08-31
【文献解读】Science 重磅成果:西湖大学团队攻克共价蛋白药物核心瓶颈,建立通用高通量速效蛋白筛选平台
321
2026-06-25
【技术讲解】信号通路系列 | Wnt/β-catenin信号通路:细胞的“信号转换器”与“命运规划师”
687
2026-04-29
【文献解读】EGFR信号通路的耐药新视角:当EGFR-TKI遇上免疫压力,肿瘤如何“金蝉脱壳”?
477
2026-04-29
【应用方向】免疫检查点核心家族:B7-CD28超家族蛋白
1085
2026-04-21
【应用方向】TIM-3:下一代肿瘤免疫检查点治疗的核心靶点
795
2026-04-21
【应用方向】SIRP家族分子详解与产品选择指南
673
2026-04-21
【应用方向】OX40-OX40L共刺激轴的T细胞存活调控
742
2026-04-21
【应用方向】LILRB家族:髓系细胞免疫检查点的研究前沿与产品解决方案
982
2026-04-21
【应用方向】LAG-3(CD223):T细胞耗竭调控网络的核心节点
901
2026-04-21
【应用方向】B7-H3(CD276):双重功能免疫检查点的分子特征与科研应用
1463
2026-04-20
【应用方向】HER2靶点蛋白:驱动肿瘤靶向治疗的核心力量
14652
2026-03-02
【技术讲解】细胞因子科学选型--常见问题解答
11258
2026-09-21





